OverviewSuggest Edit
MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients.
Applying our patented DNA methylation platform and biomarkers, we help address a large and growing unmet medical need for better cancer diagnosis and treatment information.
MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) markets of Brussels and Amsterdam under the ticker symbol "MDXH".
MDxHealth (formerly OncoMethylome Sciences) was established in 2003 and is headquartered in Belgium. Its US headquarters is located in Durham, NC.
MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies. Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.
| Type | Public | |
| Founded | 2004 | |
| HQ | Herstal, BE | Map |
| Website | mdxhealth.com | |
| Employee Ratings | More |
Recent NewsAll News
- MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
- Liquid Biopsy Market Growth Rate of 23.80% by 2026 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by QIAGEN, MDxHealth, CareDx, Inc., Immucor, Inc., Menarini Silicon Biosystems, Guardant Health, Myriad Genetics
- MDxHealth Reports Half Year 2020 Results
- MDxHealth Provides Update on Medicare Coverage for SelectMDx
Key People/Management at MDxHealth
Michael K. McGarrity
Chief Executive Officer
Koen Hoffman
Director
Joseph Sollee
Executive Vice President of Corporate Development and General Counsel
Jean-Marc Roelandt
CFO
Walter Narajowski
Director
Rudi Mariën
Director
MDxHealth Office Locations
MDxHealth has offices in Herstal, Irvine and Nijmegen
Herstal, BE (HQ)
31 Rue d'Abhooz
Nijmegen, NL
Transistorweg 7
Irvine, CA, US
15279 Alton Pkwy #100
MDxHealth Financials and Metrics
MDxHealth Revenue
Market capitalization (19-Jan-2021) | 89.8m |
Closing stock price (19-Jan-2021) | 1.0 |
MDxHealth's current market capitalization is €89.8 m.
MDxHealth Cybersecurity Score
MDxHealth Environment, Social & Governance (ESG) Ratings
MDxHealth Online and Social Media Presence
1.42k Twitter followers
MDxHealth has 1.42k Twitter Followers. The number of followers has decreased 0.4% month over month and increased 4.9% quarter over quarter
MDxHealth's Trends
Twitter Engagement Stats for @mdxhealth
915
Tweets
394
Following
1.4k
Followers
8
Tweets last 30 days
0.6
Avg. likes per Tweet
50%
Tweets with engagement
MDxHealth News and Updates
October 16, 2020
MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
Press release Regulated information. 16 October 2020, 07:00 a.m. CEST
September 14, 2020
Liquid Biopsy Market Growth Rate of 23.80% by 2026 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by QIAGEN, MDxHealth, CareDx, Inc., Immucor, Inc., Menarini Silicon Biosystems, Guardant Health, Myriad Genetics
SAN FRANCISCO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Data Bridge Market Research has added a new report titled Global Liquid Biopsy Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. Global Liqu…
August 26, 2020
MDxHealth Reports Half Year 2020 Results
Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below
August 07, 2020
MDxHealth Provides Update on Medicare Coverage for SelectMDx
Press Release Regulated Information Inside Information August 7, 2020, 7:00 CET
June 30, 2020
MDxHealth Announces its Special and Extraordinary General Shareholders’ Meetings
Press release Regulated information 30 June 2020, 7:30 a.m. CEST
MDxHealth Blogs
January 21, 2021
MDxHealth Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 11:30 p.…
January 21, 2021
MDxHealth Launches Capital Increase and Provides Preliminary 2020 Financial Results
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 04:00 p.…
MDxHealth Frequently Asked Questions
When was MDxHealth founded?
MDxHealth was founded in 2004.
Who are MDxHealth key executives?
MDxHealth's key executives are Michael K. McGarrity, Koen Hoffman and Joseph Sollee.
How many employees does MDxHealth have?
MDxHealth has 177 employees.
Who are MDxHealth competitors?
Competitors of MDxHealth include Veracyte, Dadi and Longhorn Vaccines and Diagnostics.
Where is MDxHealth headquarters?
MDxHealth headquarters is located at 31 Rue d'Abhooz, Herstal.
Where are MDxHealth offices?
MDxHealth has offices in Herstal, Irvine and Nijmegen.
How many offices does MDxHealth have?
MDxHealth has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies